⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NSRX News

Nasus Pharma Ltd.

Nasus Pharma Announces Expanded Agreement to Support Development and Commercialization of NS002 Intranasal Epinephrine Program